New York State Common Retirement Fund Mersana Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 37,235 shares of MRSN stock, worth $93,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,235
Previous 37,235
-0.0%
Holding current value
$93,832
Previous $75,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding MRSN
# of Institutions
121Shares Held
116MCall Options Held
233KPut Options Held
74K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$48.8 Million1.59% of portfolio
-
Nextech Invest Ag12.1MShares$30.4 Million3.72% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$28.5 Million2.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$21.8 Million2.94% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$21.1 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $245M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...